Navigation Links
Memory Pharmaceuticals Appoints Paul Blake to Board of Directors
Date:11/12/2007

MONTVALE, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced the appointment of Paul Blake to the Company's Board of Directors effective November 9, 2007. Dr. Blake has over 27 years of clinical development experience. He currently serves as the Senior Vice President and Chief Medical Officer of AEterna Zentaris Inc., a bio-pharmaceutical company. Previously, Dr. Blake was Senior Vice President, Clinical Research and Development for Avigenics Inc. From 2001 to 2006, Dr. Blake was with Cephalon, Inc. in the clinical research and regulatory affairs group, most recently as Executive Vice President, Worldwide Medical and Regulatory Operations. He has also served as Chief Medical Officer for MDS Proteomics, Inc. and as Medical Director for SmithKline Beecham Pharmaceuticals, where he was responsible for its worldwide clinical research and development operations.

"We are delighted to welcome Paul to the Board of Directors of Memory Pharmaceuticals," said Jonathan Fleming, Co-founder of Memory Pharmaceuticals and Chairman of the Company's Board of Directors. "Paul brings to Memory's Board a wealth of experience leading the clinical development of early and late-stage drug candidates, across a range of therapeutic areas. We believe his expertise will be of tremendous value as our pipeline matures and our compounds advance through the clinical trial process."

"I am excited to be joining the Memory Pharmaceuticals Board," stated Dr. Blake. "The Company has a robust and diverse portfolio of compounds in development for the treatment of debilitating central nervous system disorders, and I look forward to working with the Company and, in particular, the clinical developm
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
2. Removing Ovaries Before Menopause Leads to Memory, Movement Troubles
3. Boston University School of Medicine researcher recipient of Memory Ride Grant
4. New understanding of basic units of memory
5. Obesity Wont Affect Seniors Memory
6. HRT: A Boost for Libido, But Not Memory
7. Memory tasks require more coordinated brain blood flow for people with high blood pressure
8. Computerized training of working memory is a promising therapeutic strategy in ADHD
9. Alzheimers Foundation of America Holds Fifth Annual National Memory Screening Day
10. Survey Reveals Widespread Lack of Communication With Doctors About Memory Concerns
11. Memory Pharmaceuticals to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...ndia's biggest drugmaker Ranbaxy Laboratories Ltd ...ply agreement with Janssen-Ortho Inc (JOI) for a g...n the Canadian market. // The agreement was signe...diary, Ranbaxy Pharmaceuticals Canada Inc (RPCI) a...
...nternational experts from the worlds of academia, ... next month to discuss how state-of-the-art// comm...le and affordable. E-health is an emerging field...rvices and information such as electronic medical ...
...orway has granted $80 million to the National Rura...ion, child and maternal health programmes.// The ...he two programme partners - for specific activitie...a and Norway also launched a multi-partner initiat...
...iming at empowering transgenders and those affecte...) was launched here today. // 'Tai Vizhuthugal' (...ther hundreds of transgenders from Coimbatore, Mad... an aim at empowering and enabling the community t...
Other Medicine News:Health News:Delhi to Host E-health Global Meet Next Month 2Health News:Norway Grants $80 mn to India's Health Mission 2
(Date:8/15/2008)...ewswire/ -- Globus Medical, Inc., the largest,priv...d, today announced,that the first FLEXUS(TM) Inter...tigational Device Exemption ("IDE") recently grant...t Murray., The FLEXUS(TM) Spacer is placed with a... with minimal disruption to the surrounding muscul...
(Date:8/14/2008)... Continuing Education Activity, VOORHEES, N.J., A...significant cause of morbidity and mortality in re...n. The clinical manifestations of CMV disease are,... life-threatening,pneumonia, myelosuppression, ret...V infection and reduce CMV drug resistance, it is,...
(Date:8/14/2008)...dy (BiTE) showing clinical benefit in cancer,patie...recognize and attack ...FirstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a b...tary,antibodies for the treatment of cancer, infla...ublication of a Phase 1 clinical study(1) on its,B...
(Date:8/14/2008)...gy Evaluated to Enable Targeting and Increase ... LEXINGTON, Mass. and HEIDELBERG, Germany, Aug. 1...mics Research Institute (TGen) today announced,the...valuate,Next-Generation-Sequencing equipment in co...array Technology., febit,s HybSelect(TM) Technolo...
Breaking Medicine Technology:First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Large scale community protein annotation WikiProteins 5653 1Large scale community protein annotation WikiProteins 5653 2NC State breakthrough results in super hard nanocrystalline iron that can take the heat 5649 1GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 1GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 2GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 3WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10 2008 5646 1WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10 2008 5646 2
...ung and Colorectal Cancers, ROCKVILLE, Md., April ..., a clinical-stage pharmaceutical company developi...flammatory diseases,announced the presentation of...pounds. The data were presented by EntreMed scient...ch (AACR) Annual,Meeting in Los Angeles, Californi...
...16, 2007 - Introgen Therapeutics,Inc. (NASDAQ:ING...,the weekend in Los Angeles, California at the Ann... Research., Abnormality of the p53 tumor suppresso...lar defects in cancer. ADVEXIN,s,mechanism of acti...unction and the detection of abnormal p53 is a log...
Other Medicine Technology:EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 2EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 3EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 4Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4
...ally read, qualitative immunochromatographic metho...a bacterium that grows in the stomach and is assoc...ancers. FlexSure HP, available for use with either...ian with the opportunity to perform "on-the-spot" ...
OraQuick is an FDA approved rapid point-of-care fingerstick and venipuncture whole blood test used to aid in the diagnosis of HIV-1 infection. This CLIA waived test, which detects the presence of ant
Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test
...Mononucleosis test is designed to detect the IgM h...ood. The QuickVue+ Infectious Mononucleosis assay ...ive a greater sensitivity and specificity than sim...ocytes. QuickVue+ Infectious Mononucleosis is a ra...
Medicine Products: